NKTR icon

Nektar Therapeutics

132 hedge funds and large institutions have $168M invested in Nektar Therapeutics in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

0.8% more ownership

Funds ownership: 4.1%4.91% (+0.8%)

35% less call options, than puts

Call options by funds: $50K | Put options by funds: $77K

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
132
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$50K
Puts
$77K
Net Calls
Net Calls Change

Top Buyers

1 +$11.7M
2 +$11.5M
3 +$9.34M
4
Citadel Advisors
Citadel Advisors
Florida
+$4.66M
5
State Street
State Street
Massachusetts
+$2.85M

Top Sellers

1 -$4.54M
2 -$3.33M
3 -$3.25M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.73M
5
LCM
Lynx1 Capital Management
Puerto Rico
-$1.93M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$22.2M
2
$18.8M
3
$16.1M
4
$11.7M
5
$9.34M
6
$8.62M
7
$7.47M
8
$6.05M
9
$5.78M
10
$5.1M
11
$5.1M
12
$4.96M
13
$4.11M
14
$3.71M
15
$3.56M
16
$2.69M
17
$2.28M
18
$2.28M
19
$2.24M
20
$2.19M
21
$1.84M
22
$1.83M
23
$1.63M
24
$1.29M
25
$1.15M